LAMEA API Intermediate Market Size, Share & Industry Trends Analysis Report By Type (Bulk Drug Intermediates, and Chemical Intermediates), By End User (Biotech & Pharmaceutical Companies, CMO), By Application, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa API Intermediate Market would witness market growth of 10.7% CAGR during the forecast period (2023-2030).

The production of APIs requires a large amount of capital due to the process' need for highly systematic protocols, which results in the outsourcing of various APIs. Outsourcing API production offers pharmaceutical companies’ additional advantages because it eliminates the need for costly manufacturing unit installation and labor costs. Thus, outsourcing is encouraged by the need for cost savings. Strategic outsourcing enables companies to concentrate on their core competencies, resulting in increased productivity.

A drug's intended effects are achieved through an active pharmaceutical ingredient. They are also referred to as bulk medications. A chemical or biological process produces these. The expanding tendency toward improvements and developments in therapeutic medications by various pharmaceutical and biotechnology companies is projected to benefit the market. The rise of innovative drug delivery systems, and the increasing demand for personalized medication are a few of the factors anticipated to significantly contribute to the growth of the market during the projected year.

According to statistics provided by the UAE’s government under Chronic Illness & Natural Disorders in March 2023, the UAE reports 4,500 new cancer cases yearly. The primary performance metric of the pillar of top-notch healthcare in the UAE National Agenda 2021 is lowering the prevalence of diabetes and cancer-related mortality. Furthermore, creating a top-notch healthcare sector is the aim of the UAE’s government. Also, they wish to build their healthcare sector as a hub for medical tourism. This high number of patients with health issues such as diabetes mainly need products such as API intermediate. Also, other regional nations such as Brazil, and Saudi Arabia have robust healthcare sector. All these aspects are predicted to support the growth of regional market.

The Brazil market dominated the LAMEA API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.8 billion by 2030. The Argentina market is estimated to grow at a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 10.4% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide API Intermediate Market is Projected to reach USD 237.7 Billion by 2030, at a CAGR of 7.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy’s Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Bulk Drug Intermediates
• Chemical Intermediates

By End User

• Biotech & Pharmaceutical Companies
• CMO
• Others

By Application

• Analgesics
• Antidiabetic Drugs
• Anti-Infective Drugs
• Cardiovascular Drugs
• Anticancer Drugs
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Cation Pharma
• Espee Group
• Sandoo Pharmaceuticals and Chemicals Co., Ltd.
• Cipla Limited
• Cambrex Corporation
• Vertellus
• Dr.Reddy’s Laboratories Ltd.
• Evonik Industries AG (RAG-Stiftung)
• Pfizer, Inc.
• Shree Ganesh Remedies Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA API Intermediate Market, by Type
1.4.2 LAMEA API Intermediate Market, by End User
1.4.3 LAMEA API Intermediate Market, by Application
1.4.4 LAMEA API Intermediate Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. Strategies Deployed in API Intermediate Market

Chapter 5. LAMEA API Intermediate Market by Type
5.1 LAMEA Bulk Drug Intermediates Market by Country
5.2 LAMEA Chemical Intermediates Market by Country

Chapter 6. LAMEA API Intermediate Market by End User
6.1 LAMEA Biotech & Pharmaceutical Companies Market by Country
6.2 LAMEA CMO Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA API Intermediate Market by Application
7.1 LAMEA Analgesics Market by Country
7.2 LAMEA Antidiabetic Drugs Market by Country
7.3 LAMEA Anti-Infective Drugs Market by Country
7.4 LAMEA Cardiovascular Drugs Market by Country
7.5 LAMEA Anticancer Drugs Market by Country
7.6 LAMEA Others Market by Country

Chapter 8. LAMEA API Intermediate Market by Country
8.1 Brazil API Intermediate Market
8.1.1 Brazil API Intermediate Market by Type
8.1.2 Brazil API Intermediate Market by End User
8.1.3 Brazil API Intermediate Market by Application
8.2 Argentina API Intermediate Market
8.2.1 Argentina API Intermediate Market by Type
8.2.2 Argentina API Intermediate Market by End User
8.2.3 Argentina API Intermediate Market by Application
8.3 UAE API Intermediate Market
8.3.1 UAE API Intermediate Market by Type
8.3.2 UAE API Intermediate Market by End User
8.3.3 UAE API Intermediate Market by Application
8.4 Saudi Arabia API Intermediate Market
8.4.1 Saudi Arabia API Intermediate Market by Type
8.4.2 Saudi Arabia API Intermediate Market by End User
8.4.3 Saudi Arabia API Intermediate Market by Application
8.5 South Africa API Intermediate Market
8.5.1 South Africa API Intermediate Market by Type
8.5.2 South Africa API Intermediate Market by End User
8.5.3 South Africa API Intermediate Market by Application
8.6 Nigeria API Intermediate Market
8.6.1 Nigeria API Intermediate Market by Type
8.6.2 Nigeria API Intermediate Market by End User
8.6.3 Nigeria API Intermediate Market by Application
8.7 Rest of LAMEA API Intermediate Market
8.7.1 Rest of LAMEA API Intermediate Market by Type
8.7.2 Rest of LAMEA API Intermediate Market by End User
8.7.3 Rest of LAMEA API Intermediate Market by Application

Chapter 9. Company Profiles
9.1 Cation Pharma
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Espee Group
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Trials and Approvals:
9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 Cipla Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Cambrex Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Acquisition and Mergers:
9.5.3 SWOT Analysis
9.6 Vertellus
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Dr. Reddy’s Laboratories Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Evonik Industries AG (RAG-Stiftung)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Geographical Expansions:
9.8.6 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Geographical Expansions:
9.9.6 SWOT Analysis
9.10. SHREE GANESH REMEDIES LIMITED
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 SWOT Analysis

TABLE 1 LAMEA API Intermediate Market, 2019 - 2022, USD Million
TABLE 2 LAMEA API Intermediate Market, 2023 - 2030, USD Million
TABLE 3 LAMEA API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 4 LAMEA API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 5 LAMEA Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Chemical Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Chemical Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 10 LAMEA API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 11 LAMEA Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA CMO Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA CMO Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 18 LAMEA API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 19 LAMEA Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Analgesics Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Anticancer Drugs Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Anticancer Drugs Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA API Intermediate Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA API Intermediate Market by Country, 2023 - 2030, USD Million
TABLE 33 Brazil API Intermediate Market, 2019 - 2022, USD Million
TABLE 34 Brazil API Intermediate Market, 2023 - 2030, USD Million
TABLE 35 Brazil API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 36 Brazil API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 37 Brazil API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 38 Brazil API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 39 Brazil API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 40 Brazil API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 41 Argentina API Intermediate Market, 2019 - 2022, USD Million
TABLE 42 Argentina API Intermediate Market, 2023 - 2030, USD Million
TABLE 43 Argentina API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 44 Argentina API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 45 Argentina API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 46 Argentina API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 47 Argentina API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 48 Argentina API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 49 UAE API Intermediate Market, 2019 - 2022, USD Million
TABLE 50 UAE API Intermediate Market, 2023 - 2030, USD Million
TABLE 51 UAE API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 52 UAE API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 53 UAE API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 54 UAE API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 55 UAE API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 56 UAE API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia API Intermediate Market, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia API Intermediate Market, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 65 South Africa API Intermediate Market, 2019 - 2022, USD Million
TABLE 66 South Africa API Intermediate Market, 2023 - 2030, USD Million
TABLE 67 South Africa API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 68 South Africa API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 69 South Africa API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 70 South Africa API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 71 South Africa API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 72 South Africa API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 73 Nigeria API Intermediate Market, 2019 - 2022, USD Million
TABLE 74 Nigeria API Intermediate Market, 2023 - 2030, USD Million
TABLE 75 Nigeria API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 76 Nigeria API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 77 Nigeria API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 78 Nigeria API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 79 Nigeria API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 80 Nigeria API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA API Intermediate Market, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA API Intermediate Market, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 87 Rest of LAMEA API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 88 Rest of LAMEA API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Cation Pharma
TABLE 90 Key Information – Espee Group
TABLE 91 Key Information – Sandoo Pharmaceuticals and Chemicals Co., Ltd.
TABLE 92 Key Information – Cipla Limited
TABLE 93 Key Information – Cambrex Corporation
TABLE 94 Key Information – Vertellus
TABLE 95 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 96 Key Information – Evonik Industries AG
TABLE 97 Key Information – Pfizer, Inc.
TABLE 98 Key Information – SHREE GANESH REMEDIES LIMITED

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA API Intermediate Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors API intermediate market
FIG 4 Porter’s Five Forces Analysis – API Intermediate Market
FIG 5 LAMEA API Intermediate Market share by Type, 2022
FIG 6 LAMEA API Intermediate Market share by Type, 2030
FIG 7 LAMEA API Intermediate Market by Type, 2019 - 2030, USD Million
FIG 8 LAMEA API Intermediate Market share by End User, 2022
FIG 9 LAMEA API Intermediate Market share by End User, 2030
FIG 10 LAMEA API Intermediate Market by End User, 2019 - 2030, USD Million
FIG 11 LAMEA API Intermediate Market share by Application, 2022
FIG 12 LAMEA API Intermediate Market share by Application, 2030
FIG 13 LAMEA API Intermediate Market by Application, 2019 - 2030, USD Million
FIG 14 LAMEA API Intermediate Market share by Country, 2022
FIG 15 LAMEA API Intermediate Market share by Country, 2030
FIG 16 LAMEA API Intermediate Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Cation Pharma
FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
FIG 19 SWOT Analysis: Cipla Limited
FIG 20 Swot Analysis: Cambrex Corporation
FIG 21 Swot Analysis: Vertellus
FIG 22 Swot Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 23 Recent strategies and developments: Evonik Industries AG
FIG 24 Swot Analysis: Evonik Industries AG
FIG 25 Swot Analysis: Pfizer, Inc.
FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED